Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–54.
Article
PubMed
Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Article
PubMed
Google Scholar
Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
Article
PubMed
Google Scholar
Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):90.
Article
PubMed
PubMed Central
Google Scholar
Peng H, Zhang J, Zhang PP, Chen L, Tang LL, Yang XJ, et al. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019;38(1):11.
Article
PubMed
PubMed Central
Google Scholar
Pan JJ, Ng WT, Zong JF, Lee SW, Choi HC, Chan LL, et al. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016;122(21):3307–15.
Article
PubMed
Google Scholar
Cao CN, Luo JW, Gao L, Yi JL, Huang XD, Wang K, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma. Oral Oncol. 2013;49(2):175–81.
Article
PubMed
Google Scholar
Setton J, Han J, Kannarunimit D, Wuu YR, Rosenberg SA, DeSelm C, et al. Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma. Oral Oncol. 2016;53:67–73.
Article
PubMed
Google Scholar
Gu MF, Su Y, Chen XL, He WL, He ZY, Li JJ, et al. Quality of life and radiotherapy complications of Chinese nasopharyngeal carcinoma patients at different 3DCRT. Asian Pac J Cancer Prev. 2012;13(1):75–9.
Article
PubMed
Google Scholar
Wee CW, Keam B, Heo DS, Sung MW, Won TB, Wu HG. Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy. Radiat Oncol J. 2015;33(2):98–108.
Article
PubMed
PubMed Central
Google Scholar
Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Tu WY, et al. Outcomes and xerostomia after postoperative radiotherapy for oral and oropharyngeal carcinoma. Head Neck. 2014;36(10):1467–73.
PubMed
Google Scholar
McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, et al. Long-term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102(2):340–52.
Article
PubMed
Google Scholar
Gabryś HS, Buettner F, Sterzing F, Hauswald H, Bangert M. Parotid gland mean dose as a xerostomia predictor in low-dose domains. Acta Oncol. 2017;56(9):1197–203.
Article
PubMed
Google Scholar
Lin DS, Jen YM, Lee JC, Liu SC, Lin YS. Recurrence of nasopharyngeal carcinoma in the parotid region after parotid-gland-sparing radiotherapy. J Formos Med Assoc. 2011;110(10):655–60.
Article
PubMed
Google Scholar
Pan XB, Chen KH, Huang ST, Jiang YM, Ma JL, Liang ZG, Qu S, Li L, Chen L, Zhu XD. Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma. Oncotarget. 2017;8(44):78096–104.
Article
PubMed
PubMed Central
Google Scholar
Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, Leemans CR, Slotman BJ. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol. 2009;90(2):189–95.
Article
PubMed
Google Scholar
Gupta N, Pal M, Rawat S, et al. Radiation-induced dental caries, prevention and treatment—A systematic review. Natl J Maxillofac Surg. 2015;6(2):160–6.
Article
PubMed
PubMed Central
Google Scholar
Greco E, Simic T, Ringash J, Tomlinson G, Inamoto Y, Martino R. Dysphagia treatment for patients with head and neck cancer undergoing radiation therapy: a meta-analysis review. Int J Radiat Oncol Biol Phys. 2018;101(2):421–44.
Article
PubMed
Google Scholar
Sun X, Su S, Chen C, Han F, Zhao C, Xiao W, Deng X, Huang S, Lin C, Lu T. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2014;110(3):398–403.
Article
Google Scholar
Yang K, Xie W, Zhang X, Wang Y, Shou A, Wang Q, Tian J, Yang J, Li G. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era. Aging. 2021;13(14):18645–57.
Article
PubMed
PubMed Central
Google Scholar
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341–6.
Article
PubMed
Google Scholar
Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res Off J Jpn Soc Hypertens. 2014;37(4):253–390.
Article
Google Scholar
Kuwabara M, Kanbay M, Niwa K, Ae R, Andres-Hernando A, Roncal-Jimenez CA, Garcia G, Sánchez-Lozada LG, Rodriguez-Iturbe B, Hisatome I, et al. Hyperosmolarity and increased serum sodium concentration are risks for developing hypertension regardless of salt intake: a five-year cohort study in Japan. Nutrients. 2020;12(5):1422.
Article
PubMed Central
Google Scholar
Deng Q, Liu J, Li Q, Chen K, Liu Z, Shen Y, Niu P, Yang Y, Zou Y, Yang X. Interaction of occupational manganese exposure and alcohol drinking aggravates the increase of liver enzyme concentrations from a cross-sectional study in China. Environ Health Glob Access Sci Source. 2013;12:30.
Google Scholar
Sim C, Soong YL, Pang E, Lim C, Walker GD, Manton DJ, Reynolds EC, Wee J. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up. Aust Dent J. 2018;63(2):217–23.
Article
PubMed
Google Scholar
Beetz I, Schilstra C, Burlage FR, Koken PW, Doornaert P, Bijl HP, et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors. Radiother Oncol. 2012;105(1):86–93.
Article
PubMed
Google Scholar
Teng F, Fan W, Luo Y, Ju Z, Gong H, Ge R, et al. Reducing xerostomia by comprehensive protection of salivary glands in intensity-modulated radiation therapy with helical tomotherapy technique for head-and-neck cancer patients: a prospective observational study. Biomed Res Int. 2019;2019:2401743.
PubMed
PubMed Central
Google Scholar
Stiubea-Cohen R, David R, Neumann Y, Krief G, Deutsch O, Zacks B, Aframian DJ, Palmon A. Effect of irradiation on cell transcriptome and proteome of rat submandibular salivary glands. PLoS ONE. 2012;7(7):e40636.
Article
PubMed
PubMed Central
Google Scholar
Lan X, Chan JYK, Pu JJ, Qiao W, Pang S, Yang WF, Wong KCW, Kwong DLW, Su YX. Saliva electrolyte analysis and xerostomia-related quality of life in nasopharyngeal carcinoma patients following intensity-modulated radiation therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2020;150:97–103.
Article
Google Scholar
Yang P, Elhalawani H, Shi Y, Tang Y, Han Y, Zhao Y, et al. A large-scale retrospective study of the overall survival outcome in nasopharyngeal carcinoma with hypertension in Chinese population. Oncotarget. 2017;8(43):75577–86.
Article
PubMed
PubMed Central
Google Scholar
Kawamoto M, Yamada SI, Gibo T, Kajihara R, Nagashio S, Tanaka H, Yajima J, Takizawa A, Kondo E, Sakai H, et al. Relationship between dry mouth and hypertension. Clin Oral Investig. 2021;25(9):5217–25.
Article
PubMed
Google Scholar
Streckfus CF. Salivary function and hypertension: a review of the literature and a case report. J Am Dent Assoc. 1995;126(7):1012–7.
Article
PubMed
Google Scholar
Böhm R, van Baak M, van Hooff M, Moy J, Rahn KH. Salivary flow in borderline hypertension. Klin Wochenschr. 1985;63(Suppl 3):154–6.
PubMed
Google Scholar
Varellis MLZ, Gonçalves MLL, Pavesi VCS, Horliana A, de Fátima Teixeira da Silva D, Motta LJ, et al. Evaluation of photobiomodulation in salivary production of patients with xerostomy induced by anti-hypertensive drugs: Study protocol clinical trial (SPIRIT compliant). Medicine. 2020;99(16):83.
Article
Google Scholar
López-Pintor RM, López-Pintor L, Casañas E, de Arriba L, Hernández G. Risk factors associated with xerostomia in haemodialysis patients. Med Oral Patol Oral Cir Bucal. 2017;22(2):e185–92.
PubMed
PubMed Central
Google Scholar
Takakura AC, Moreira TS, De Luca LA Jr, Renzi A, Menani JV, Colombari E. Effects of AV3V lesion on pilocarpine-induced pressor response and salivary gland vasodilation. Brain Res. 2005;1055(1–2):111–21.
Article
PubMed
Google Scholar
Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, et al. Weekly low-dose versus three-weekly high-dose cisplatin for concurrent chemoradiation in locoregionally advanced non-nasopharyngeal head and neck cancer: a systematic review and meta-analysis of aggregate data. Oncologist. 2017;22(9):1056–66.
Article
PubMed
PubMed Central
Google Scholar
Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 2006;65(1):161–8.
Article
PubMed
Google Scholar
Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80(3):661–8.
Article
PubMed
Google Scholar
Kaae JK, Johnsen L, Hansen CR, Kristensen MH, Brink C, Eriksen JG. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy. Acta Oncol (Stockholm, Sweden). 2019;58(10):1366–72.
Article
Google Scholar
Liu WS, Lee SP, Lee JK, Su MC, Chen GD, Lee HS, Lee H. Factors influencing the parotid function in nasopharyngeal carcinoma treated with parotid-sparing radiotherapy. Jpn J Clin Oncol. 2006;36(10):626–31.
Article
PubMed
Google Scholar
Teshima K, Murakami R, Tomitaka E, Nomura T, Toya R, Hiraki A, Nakayama H, Hirai T, Shinohara M, Oya N, et al. Radiation-induced parotid gland changes in oral cancer patients: correlation between parotid volume and saliva production. Jpn J Clin Oncol. 2010;40(1):42–6.
Article
PubMed
Google Scholar
Teshima K, Murakami R, Yoshida R, Nakayama H, Hiraki A, Hirai T, Nakaguchi Y, Tsujita N, Tomitaka E, Furusawa M, et al. Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancer. J Radiat Res. 2012;53(3):492–6.
PubMed
Google Scholar
Pan XB, Liu Y, Huang ST, Chen KH, Jiang YM, Zhu XD. Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Medicine. 2019;98(36):e17030.
Article
PubMed
PubMed Central
Google Scholar
Liu L, Fei Z, Chen M, Zhao L, Su H, Gu D, Lin B, Cai X, Lu L, Gao M, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study. Radiat Oncol (Lond, Engl). 2018;13(1):148.
Article
Google Scholar
Zeng L, Tian YM, Sun XM, Chen CY, Han F, Xiao WW, Deng XW, Lu TX. Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors. Br J Cancer. 2014;110(1):49–54.
Article
PubMed
Google Scholar
Shinohara C, Ito K, Takamatsu K, Ogawa M, Kajii Y, Nohno K, Sugano A, Funayama S, Katakura A, Nomura T, et al. Factors associated with xerostomia in perimenopausal women. J Obstet Gynaecol Res. 2021;47(10):3661–8.
Article
PubMed
Google Scholar
Pérez-González A, Suárez-Quintanilla JA, Otero-Rey E, Blanco-Carrión A, Gómez-García FJ, Gándara-Vila P, Martín-Biedma B, Pérez-Sayáns M. Association between xerostomia, oral and general health, and obesity in adults. A cross-sectional pilot study. Med Oral Patol Oral Cir Bucal. 2021;26(6):e762–9.
Article
PubMed
PubMed Central
Google Scholar
Sommat K, Hussain A, Ong WS, Yit NLF, Khoo JBK, Soong YL, et al. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer—a prospective cohort analysis. Radiother Oncol. 2019;138:149–57.
Article
PubMed
Google Scholar
Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006;66(2):445–53.
Article
PubMed
Google Scholar